Show simple item record

dc.contributor.advisorMassaro Ceballos, Mónica María 
dc.creatorGarcía Rodríguez, María Carmen 
dc.creatorMontenegro Montúfar, Álvaro 
dc.date.accessioned2017-05-17T16:44:59Z
dc.date.available2017-05-17T16:44:59Z
dc.date.created2017-05-08
dc.date.issued2017 
dc.identifier.urihttp://repository.urosario.edu.co/handle/10336/13387
dc.descriptionIntroducción: La adherencia y persistencia a terapias farmacológicas son unas de las estrategias de prevención secundaria más discutidas y estudiadas a nivel mundial. En las últimas décadas ha crecido enormemente el interés en el rol que desempeñan en los resultados clínicos y sociales, por lo que diversos estudios han estudiado el impacto de diferentes técnicas pro-adherencia Vs el manejo habitual o la no intervención, arrojando que la mayoría de estas alternativas resultan ser más eficaces que la no intervención. Sin embargo, esto continúa siendo un reto para el personal de salud y la sociedad en general, no solo por los enormes gastos en salud que genera la falta de adherencia y persistencia a la medicación prescrita, sino también por su impacto negativo en la calidad de vida y mortalidad de la población en general. Objetivo: Comparar la persistencia en la toma de medicamentos de uso crónico entre anticonceptivos, hipolipemiantes, flebotónicos, antihipertensivos y antirresortivos de un programa de reposición periódica de medicamentos sin costo, de acuerdo a variables demográficas, de dispensación y del modelo de reposición, en pacientes adultos prescritos con estas terapias y seguidos durante dos años. Pacientes y métodos: Se llevó a cabo un estudio de casos y controles anidados en una cohorte a partir de la base de datos de un programa de reposición periódica de medicamentos sin costo de operación nacional, diseñado para mejorar la adherencia y persistencia a medicamentos de varios grupos terapéuticos de uso crónico y anticonceptivos, en pacientes adultos (N= 57.576), residentes en 378 municipios de Colombia durante dos años de seguimiento. Se consideró que un paciente es persistente a una terapia prescrita cuando el tiempo durante el cual continúa con el tratamiento fuera ≥80% del periodo de seguimiento, en términos de frecuencia de recompra y tiempo de uso. Posteriormente se realizó un análisis bivariado con el fin de identificar la relación entre las variables del estudio y finalmente se evaluó el poder predictor de las variables estudiadas en la persistencia al uso de la terápia a los seis, 12 y 17 meses de tratamiento, a través de una regresión logística binaria. Resultados: Las variables predictoras más relevantes para el desenlace de persistencia a los seis, 12 y 17 meses de tratamiento fueron la edad, (para anticonceptivos, hipolipemiantes y flebotónicos), el tipo de reposición para antihipertensivos, y el tipo de entrega para los antirresortivos. Conclusión: La persistencia al uso de terapias de uso crónico y anticonceptivos, en el marco de un programa de reposición de medicamentos sin costo es de etiología multifactorial; donde están involucradas tanto variables propias del paciente como del medicamento y del modelo de reposición utilizado. La no persistencia al uso de los medicamentos estudiados fue alta en todos los grupos terapéuticos, lo cual es llamativo considerando que se trata de un programa de reposición de medicamentos totalmente gratuito.
dc.description.abstractIntroduction: Adherence and persistence to pharmacological therapies are of the most discussed and studied secondary prevention strategies worldwide. In the last decades, the interest in their role in clinical and social outcomes, has increased considerably; therefore, several research had studied the impact of different pro- adherence techniques compared to non-intervention (usual management), these alternatives have been more effective than non-intervention. However, it is still a challenge for clinicians and general society, not just because of the huge amount of health expenditures generated by the lack of adherence and persistence to prescribed medication, but also because of its negative impact on quality of life and mortality of general population. Objetive: Compare persistence to chronic contraceptives, lipid-lowerings agents, phlebotonic, antihypertensive and antiresorptive drugs in a non-cost periodic drug replacement program according to demographic, dispensing and replacement model variables in adult patients prescribed with these therapies and followed over two years. Patients and methods: A case-control study nested in a retrospective cohort was conducted from a database of a national periodic drug replacement program without costs, designed to improve drug adherence and persistence in several therapeutic groups (N = 57,576), living in 378 towns of Colombia, during a two years’ follow-up. Persistence to a prescribed therapy is defined as frequency of repurchase and duration of use greater than 80% throug the entire treatment. Subsequently, a bivariate analysis was performed to identify the association between studied variables and finally their predictive power in persistence to the evaluated therapy after 6, 12 and 17 months, through a binary logistic regression. Results: The most relevant predictor variables of persistence as an outcome at six, 12 and 17 months were: age (for contraceptives, lipid-lowering agents and phlebotonics), “type of replacement” for antihypertensives, and “type of delivery” for antiresorptives. Conclusion: Persistence to chronic therapies and contraceptives, has multifactorial etiology in a no - cost drug replacement program; where patient's, drug’s and replacement model variables are involved. Non-persistence to studied drugs was high in all therapeutic groups, which is striking considering that it is a totally free drug replacement program.
dc.format.mimetypeapplication/pdf
dc.language.isospa
dc.rights.urihttp://creativecommons.org/licenses/by-nc/2.5/co/
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectCumplimiento de la medicación
dc.subjectTerapias crónicas
dc.subjectAnticonceptivos
dc.subjectAdherencia
dc.subjectPersistencia
dc.subjectPrograma
dc.subjectReposición gratuita
dc.subjectReposición sin costo
dc.subjectMedicamentos
dc.subject.ddcIncidencia & prevención de la enfermedad 
dc.subject.lembEpidemiología
dc.titleAnálisis de persistencia en la toma de medicamentos de uso crónico en usuarios de un programa de reposición periódica de medicamentos sin costo durante dos años en Colombia
dc.typemasterThesis
dc.publisherUniversidad del Rosario
dc.creator.degreeMagíster en Epidemiología
dc.publisher.programMaestría en Epidemiología
dc.publisher.departmentFacultad de medicina
dc.subject.keywordMedication compliance
dc.subject.keywordChronic therapies
dc.subject.keywordContraceptives
dc.subject.keywordAdherence
dc.subject.keywordPersistence
dc.subject.keywordProgram
dc.subject.keywordFree replacement
dc.subject.keywordNon-cost replacement
dc.subject.keywordMedications
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.subject.decsEpidemiología
dc.subject.decsSalud publica
dc.subject.decsMedicamentos
dc.subject.decsAnticonceptivos
dc.type.spaTesis de maestría
dc.rights.accesoAbierto (Texto Completo)
dc.description.embargo2019-08-01 06:01:01: Script de automatizacion de embargos. info:eu-repo/date/embargoEnd/2019-05-16
dc.type.hasVersioninfo:eu-repo/semantics/acceptedVersion
dc.source.bibliographicCitationDilla T VA, Lizán L, Sacristán JA. . Adherencia y persistencia terapéutica: causas, consecuencias y estrategias de mejora. . Atención Primaria 41:342–8.
dc.source.bibliographicCitationCdlC E. El futuro de la asistencia sanitaria y de la atención a las personas mayores: garantizar la accesibilidad, la calidad y la sostenibilidad financiera. Bruselas: Comunidad Europea. Informe Com: 2001 Contract No.: 12.
dc.source.bibliographicCitationR.N. Atención innovadora a las condiciones crónicas: más necesaria que nunca. Revista de Innovación Sanitaria y Atención Integrada. 2009;1:3.
dc.source.bibliographicCitationMdSyP S. Política de Atención Integral en Salud. Bogotá D.C. Enero de 2016.
dc.source.bibliographicCitationIsrael Cruz-Velandia CD-C AF-M, Solángel García-Ruiz. Characterization of research on disability in Colombia 2005-2012. Rev Fac Med. 2013;61(2):101 -9.
dc.source.bibliographicCitationGaviria C CL, Dávila C, Burgos G, Girón S. Encuesta Nacional de Demografía y Salud. In: Social MdSyP, editor. http://profamilia.org.co/docs/Libro RESUMEN EJECUTIVO.pdf: Profamilia; 2015.
dc.source.bibliographicCitationICBF ICdBF-. Embarazo Adolescente. http://www.icbf.gov.co/portal/page/portal/Observatorio1/Boletines/2015/embaraz o-adolescente-web2015.pdf2015.
dc.source.bibliographicCitationDinger J, Minh TD, Buttmann N, Bardenheuer K. Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen. Obstet Gynecol. 2011;117(1):33-40.
dc.source.bibliographicCitationPotter L OD, de Leon-Wong E, Canamar R. . Measuring compliance among oral contraceptive users. Fam Plann Perspect. 1996;28(4):154-8.
dc.source.bibliographicCitationOsterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97.
dc.source.bibliographicCitationPeterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2003;60(7):657-65.
dc.source.bibliographicCitationHaynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. The Cochrane database of systematic reviews. 2008(2):CD000011.
dc.source.bibliographicCitationGuilbert JJ. The world health report 2002 - reducing risks, promoting healthy life. Education for health. 2003;16(2):230.
dc.source.bibliographicCitationDiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Medical care. 2002;40(9):794-811.
dc.source.bibliographicCitationSchiff GD, Fung S, Speroff T, McNutt RA. Decompensated heart failure: symptoms, patterns of onset, and contributing factors. The American journal of medicine. 2003;114(8):625-30.
dc.source.bibliographicCitationMukhtar O, Weinman J, Jackson SH. Intentional non-adherence to medications by older adults. Drugs & aging. 2014;31(3):149-57.
dc.source.bibliographicCitationH S. Noncompliance with medications: an economic tragedy with important implications for health care reform. Task Force for Compliance Report, 1993.
dc.source.bibliographicCitationLegido-Quigley H, Camacho Lopez PA, Balabanova D, Perel P, Lopez-Jaramillo P, Nieuwlaat R, et al. Patients' knowledge, attitudes, behaviour and health care experiences on the prevention, detection, management and control of hypertension in Colombia: a qualitative study. PloS one. 2015;10(4):e0122112.
dc.source.bibliographicCitationNarendran R NM. Influence of pharmaceutical marketing on prescription practices of physicians. J Indian Med Assoc enero de 2013;111(1):47-50.
dc.source.bibliographicCitationRoberts AW CG, Esserman DA, Roth MT, Weinberger M, Farley JF. Patterns of medication adherence and health care utilization among patients with chronic disease who were enrolled in a pharmacy assistance program. North Carolina medical journal. 2014;75(5):310-8.
dc.source.bibliographicCitationLee SK, Kang BY, Kim HG, Son YJ. Predictors of medication adherence in elderly patients with chronic diseases using support vector machine models. Healthcare informatics research. 2013;19(1):33-41.
dc.source.bibliographicCitationLaffer MS, Feldman SR. Improving medication adherence through technology: analyzing the managing meds video challenge. Skin research and technology : official journal of International Society for Bioengineering and the Skin. 2014;20(1):62-6.
dc.source.bibliographicCitationTuldra A, Fumaz CR, Ferrer MJ, Bayes R, Arno A, Balague M, et al. Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. Journal of acquired immune deficiency syndromes. 2000;25(3):221-8.
dc.source.bibliographicCitationKhanna R, Pace PF, Mahabaleshwarkar R, Basak RS, Datar M, Banahan BF. Medication adherence among recipients with chronic diseases enrolled in a state Medicaid program. Population health management. 2012;15(5):253-60.
dc.source.bibliographicCitationAtkins D, Chang SM, Gartlehner G, Buckley DI, Whitlock EP, Berliner E, et al. Assessing applicability when comparing medical interventions: AHRQ and the Effective Health Care Program. Journal of clinical epidemiology. 2011;64(11):1198- 207.
dc.source.bibliographicCitationPaterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of internal medicine. 2000;133(1):21-30.
dc.source.bibliographicCitationD L. Opinions survey report No. 41 Contraception and Sexual Health. 2008/09. 2009.
dc.source.bibliographicCitationRosenberg MJ, Waugh MS, Burnhill MS. Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation. Fam Plann Perspect. 1998;30(2):89-92, 104.
dc.source.bibliographicCitationCleland J, Conde-Agudelo A, Peterson H, Ross J, Tsui A. Contraception and health. Lancet. 2012;380(9837):149-56.
dc.source.bibliographicCitationColombia Cd. Ley Estatutaria. 2015(1751):1-13.
dc.source.bibliographicCitationGlasgow RE, Hiss RG, Anderson RM, Friedman NM, Hayward RA, Marrero DG, et al. Report of the health care delivery work group: behavioral research related to the establishment of a chronic disease model for diabetes care. Diabetes care. 2001;24(1):124-30.
dc.source.bibliographicCitationGolin CE, Liu H, Hays RD, Miller LG, Beck CK, Ickovics J, et al. A prospective study of predictors of adherence to combination antiretroviral medication. Journal of general internal medicine. 2002;17(10):756-65.
dc.source.bibliographicCitationGifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of acquired immune deficiency syndromes. 2000;23(5):386-95.
dc.source.bibliographicCitationPerreault S, Ellia L, Dragomir A, Cote R, Blais L, Berard A, et al. Effect of statin adherence on cerebrovascular disease in primary prevention. The American journal of medicine. 2009;122(7):647-55.
dc.source.bibliographicCitationShalev V, Chodick G, Silber H, Kokia E, Jan J, Heymann AD. Continuation of statin treatment and all-cause mortality: a population-based cohort study. Archives of internal medicine. 2009;169(3):260-8.
dc.source.bibliographicCitationHo PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Archives of internal medicine. 2006;166(17):1836-41.
dc.source.bibliographicCitationSalas M, Hughes D, Zuluaga A, Vardeva K, Lebmeier M. Costs of medication nonadherence in patients with diabetes mellitus: a systematic review and critical analysis of the literature. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2009;12(6):915-22.
dc.source.bibliographicCitationShin S, Song H, Oh SK, Choi KE, Kim H, Jang S. Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients. Hypertension research : official journal of the Japanese Society of Hypertension. 2013;36(11):1000-5.
dc.source.bibliographicCitationChoudhry NK, Avorn J, Glynn RJ, Antman EM, Schneeweiss S, Toscano M, et al. Full coverage for preventive medications after myocardial infarction. The New England journal of medicine. 2011;365(22):2088-97.
dc.source.bibliographicCitationRector TS, Venus PJ. Do drug benefits help Medicare beneficiaries afford prescribed drugs? Health affairs. 2004;23(4):213-22.
dc.source.bibliographicCitationStroupe KT, Teal EY, Tu W, Weiner M, Murray MD. Association of refill adherence and health care use among adults with hypertension in an urban health care system. Pharmacotherapy. 2006;26(6):779-89.
dc.source.bibliographicCitationPiette JD RA, Silveira MJ, Hayward R, McHorney CA. Medication cost problems among chronically ill adults in the US: did the financial crisis make a bad situation even worse? . Patient preference and adherence. 2011;5:187 - 94.
dc.source.bibliographicCitationWilson J, Axelsen K, Tang S. Medicaid prescription drug access restrictions: exploring the effect on patient persistence with hypertension medications. The American journal of managed care. 2005;11 Spec No:SP27-34.
dc.source.bibliographicCitationSteiner JF, Ho PM, Beaty BL, Dickinson LM, Hanratty R, Zeng C, et al. Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Circulation Cardiovascular quality and outcomes. 2009;2(5):451-7.
dc.source.bibliographicCitationLeung DY, Bai X, Leung AY, Liu BC, Chi I. Prevalence of medication adherence and its associated factors among community-dwelling Chinese older adults in Hong Kong. Geriatr Gerontol Int. 2015;15(6):789-96.
dc.source.bibliographicCitationRolnick SJ PP, Hedblom BD, Asche SE, Bruzek RJ. Patient characteristics associated with medication adherence. Clin Med Res. 2013;11(2):54-65.
dc.source.bibliographicCitationYap AF, Thirumoorthy T, Kwan YH. Systematic review of the barriers affecting medication adherence in older adults. Geriatr Gerontol Int. 2015.
dc.source.bibliographicCitationAhmad A, Hugtenburg J, Welschen LM, Dekker JM, Nijpels G. Effect of medication review and cognitive behaviour treatment by community pharmacists of patients discharged from the hospital on drug related problems and compliance: design of a randomized controlled trial. BMC public health. 2010;10:133.
dc.source.bibliographicCitationBriesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. Journal of general internal medicine. 2007;22(6):864-71.
dc.source.bibliographicCitationBurge S, White D, Bajorek E, Bazaldua O, Trevino J, Albright T, et al. Correlates of medication knowledge and adherence: findings from the residency research network of South Texas. Family medicine. 2005;37(10):712-8.
dc.source.bibliographicCitationMoreau C, Bouyer J, Gilbert F, Group C, Bajos N. Social, demographic and situational characteristics associated with inconsistent use of oral contraceptives: evidence from France. Perspect Sex Reprod Health. 2006;38(4):190-6.
dc.source.bibliographicCitationBenito Lourenc ̧oa, Katia T. Kozub, Gabriela N. Lealc, Marco F. Silvab, Elisabeth G.C. Fernandesb, Camila M.P. Françab, Fernando H.C. Souzad, Clovis A. Silva. Contraception for adolescents with chronic rheumatic diseases. rev bras reumatol 2017;57(1):73–81.
dc.source.bibliographicCitationMunro S, Lewin S, Swart T, Volmink J. A review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS? BMC Public Health. 2007;7:104.
dc.source.bibliographicCitationO'Carroll R, Whittaker J, Hamilton B, Johnston M, Sudlow C, Dennis M. Predictors of adherence to secondary preventive medication in stroke patients. Ann Behav Med. 2011;41(3):383-90.
dc.source.bibliographicCitationChisholm MA, Williamson GM, Lance CE, Mulloy LL. Predicting adherence to immunosuppressant therapy: a prospective analysis of the theory of planned behaviour. Nephrol Dial Transplant. 2007;22(8):2339-48.
dc.source.bibliographicCitationLin EH, Katon W, Rutter C, Simon GE, Ludman EJ, Von Korff M, et al. Effects of enhanced depression treatment on diabetes self-care. Ann Fam Med. 2006;4(1):46-53.
dc.source.bibliographicCitationPearce KA, Love MM, Shelton BJ, Schoenberg NE, Williamson MA, Barron MA, et al. Cardiovascular risk education and social support (CaRESS): report of a randomized controlled trial from the Kentucky Ambulatory Network (KAN). J Am Board Fam Med. 2008;21(4):269-81.
dc.source.bibliographicCitationPowell KM, Edgren B. Failure of educational videotapes to improve medication compliance in a health maintenance organization. Am J Health Syst Pharm. 1995;52(20):2196-9.
dc.source.bibliographicCitationLee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296(21):2563-71.
dc.source.bibliographicCitationPowers BJ, Danus S, Grubber JM, Olsen MK, Oddone EZ, Bosworth HB. The effectiveness of personalized coronary heart disease and stroke risk communication. Am Heart J. 2011;161(4):673-80.
dc.source.bibliographicCitationHoffman L, Enders J, Luo J, Segal R, Pippins J, Kimberlin C. Impact of an antidepressant management program on medication adherence. Am J Manag Care. 2003;9(1):70-80.
dc.source.bibliographicCitationSabrina Mueller a, Thomas Wilke a, Benno Bechtel b, Yogesh Suresh Punekar c, Karen Mitzner d, J. Christian Virchow. Non-persistence and non-adherence to long- acting COPD medication therapy: A retrospective cohort study based on a large German claims dataset. Respiratory Medicine 122 (2017) 1e11.
dc.source.bibliographicCitationSun P, Lian J. Treatment adherence in newly diagnosed type 2 diabetes: patient characteristics and long-term impact of adherence on inpatient care utilization. Postgrad Med. 2016:1-8.
dc.source.bibliographicCitationJiang Y, Ni W. Estimating the Impact of Adherence to and Persistence with Atypical Antipsychotic Therapy on Health Care Costs and Risk of Hospitalization. Pharmacotherapy. 2015;35(9):813-22.
dc.source.bibliographicCitationRannanheimo PK, Tiittanen P, Hartikainen J, Helin-Salmivaara A, Huupponen R, Vahtera J, et al. Impact of Statin Adherence on Cardiovascular Morbidity and All-Cause Mortality in the Primary Prevention of Cardiovascular Disease: A Population-Based Cohort Study in Finland. Value Health. 2015;18(6):896-905.
dc.source.bibliographicCitationBlack AY, Guilbert E, Hassan F, Chatziheofilou I, Lowin J, Jeddi M, et al. The Cost of Unintended Pregnancies in Canada: Estimating Direct Cost, Role of Imperfect Adherence, and the Potential Impact of Increased Use of Long-Acting Reversible Contraceptives. J Obstet Gynaecol Can. 2015;37(12):1086-97.
dc.source.bibliographicCitationRoberts AW, Crisp GD, Esserman DA, Roth MT, Weinberger M, Farley JF. Patterns of medication adherence and health care utilization among patients with chronic disease who were enrolled in a pharmacy assistance program. North Carolina medical journal. 2014;75(5):310-8.
dc.source.bibliographicCitationSocial MdSyP. Política de Atención Integral en Salud. Bogotá D.C.Enero de 2016.
dc.source.bibliographicCitationLey 100 de 1993, , art 153 (1993).
dc.source.bibliographicCitationLey 1438 de 2011.
dc.source.bibliographicCitationMoore JM, Shartle D, Faudskar L, Matlin OS, Brennan TA. Impact of a patient- centered pharmacy program and intervention in a high-risk group. J Manag Care Pharm. 2013;19(3):228-36.
dc.source.bibliographicCitationSoto A, Avila X, Cordova P, Fernandez P, Lopez M, Villa LA, et al. Impact of a pharmacotherapy plan to improve adherence for patients with type-2 diabetes and hypertension in a Chilean hospital. Int J Clin Pharm. 2015;37(5):734-8.
dc.source.bibliographicCitationLemmens LC, Molema CC, Versnel N, Baan CA, de Bruin SR. Integrated care programs for patients with psychological comorbidity: A systematic review and meta- analysis. J Psychosom Res. 2015;79(6):580-94.
dc.source.bibliographicCitationNavarro J, Perez M, Curran A, Burgos J, Feijoo M, Torrella A, et al. Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain. AIDS Patient Care STDS. 2014;28(10):537-42.
dc.source.bibliographicCitationBurudpakdee C, Khan ZM, Gala S, Nanavaty M, Kaura S. Impact of patient programs on adherence and persistence in inflammatory and immunologic diseases: a meta-analysis. Patient Prefer Adherence. 2015;9:435-48.
dc.source.bibliographicCitationPark J, Jackson J, Skinner E, Ranghell K, Saiers J, Cherney B. Impact of an adherence intervention program on medication adherence barriers, asthma control, and productivity/daily activities in patients with asthma. J Asthma. 2010;47(10):1072-7.
dc.source.bibliographicCitationHo PM, Lambert-Kerzner A, Carey EP, Fahdi IE, Bryson CL, Melnyk SD, et al. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. JAMA Intern Med. 2014;174(2):186-93.
dc.source.bibliographicCitationBrummel A, Carlson AM. Comprehensive Medication Management and Medication Adherence for Chronic Conditions. J Manag Care Spec Pharm. 2016;22(1):56-62.
dc.source.bibliographicCitationTrummer JrED. Adherence to a exible extended regimen for oral hormonal contraception provided in blister packaging compared with an adherence- supporting digital tablet dispenser: historical comparison of data from two clinical studies. International Journal of Women’s Health 2016:8 351–356.
dc.source.bibliographicCitationZhang NJ, Terry A, McHorney CA. Impact of health literacy on medication adherence: a systematic review and meta-analysis. Ann Pharmacother. 2014;48(6):741-51.
dc.source.bibliographicCitationPerl S, Niederl E, Kos C, Mrak P, Ederer H, Rakovac I, et al. Randomized Evaluation of the Effectiveness of a Structured Educational Program for Patients With Essential Hypertension. Am J Hypertens. 2015.
dc.source.bibliographicCitationWald DS, Butt S, Bestwick JP. One-way Versus Two-way Text Messaging on Improving Medication Adherence: Meta-analysis of Randomized Trials. The American journal of medicine. 2015;128(10):1139.e1-5.
dc.source.bibliographicCitationPark LG, Howie-Esquivel J, Chung ML, Dracup K. A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Educ Couns. 2014;94(2):261-8.
dc.source.bibliographicCitationDeKoekkoek T, Given B, Given CW, Ridenour K, Schueller M, Spoelstra SL. mHealth SMS text messaging interventions and to promote medication adherence: an integrative review. J Clin Nurs. 2015;24(19-20):2722-35.
dc.source.bibliographicCitationHall RL, Willgoss T, Humphrey LJ, Kongso JH. The effect of medical device dose- memory functions on patients' adherence to treatment, confidence, and disease self- management. Patient Prefer Adherence. 2014;8:775-88.
dc.source.bibliographicCitationSutton S, Kinmonth AL, Hardeman W, Hughes D, Boase S, Prevost AT, et al. Does electronic monitoring influence adherence to medication? Randomized controlled trial of measurement reactivity. Ann Behav Med. 2014;48(3):293-9.
dc.source.bibliographicCitationChecchi KD, Huybrechts KF, Avorn J, Kesselheim AS. Electronic medication packaging devices and medication adherence: a systematic review. JAMA. 2014;312(12):1237-47.
dc.source.bibliographicCitationWood CL, Clements SA, McFann K, Slover R, Thomas JF, Wadwa RP. Use of Telemedicine to Improve Adherence to American Diabetes Association Standards in Pediatric Type 1 Diabetes. Diabetes Technol Ther. 2016;18(1):7-14.
dc.source.bibliographicCitationSantos MV, Oliveira DC, Novaes Mde A. A telehealth strategy for increasing adherence in the treatment of hypertension in primary care. Telemed J E Health. 2013;19(4):241-7.
dc.source.bibliographicCitationHou JG, Murphy P, Tang AW, Khandelwal N, Duncan I, Pegus CL. Impact of an online prescription management account on medication adherence. Am J Manag Care. 2012;18(3):e86-90.
dc.source.bibliographicCitationIyengar RN, Balagere DS, Henderson RR, LeFrancois AL, Rabbitt RM, Frazee SG. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol. Journal of managed care & specialty pharmacy. 2014;20(8):851-61.
dc.source.bibliographicCitationTeeter BS, Kavookjian J. Telephone-based motivational interviewing for medication adherence: a systematic review. Transl Behav Med. 2014;4(4):372-81.
dc.source.bibliographicCitationColombo GL, Agabiti-Rosei E, Margonato A, Mencacci C, Montecucco CM, Trevisan R. Off-patent generic medicines vs. off-patent brand medicines for six reference drugs: a retrospective claims data study from five local healthcare units in the Lombardy Region of Italy. PLoS One. 2013;8(12):e82990.
dc.source.bibliographicCitationColombo GL, Agabiti-Rosei E, Margonato A, Mencacci C, Montecucco CM, Trevisan R, et al. Impact of substitution among generic drugs on persistence and adherence: A retrospective claims data study from 2 Local Healthcare Units in the Lombardy Region of Italy. Atheroscler Suppl. 2016.
dc.source.bibliographicCitationHelin-Salmivaara A, Korhonen MJ, Alanen T, Huupponen R. Impact of out-of- pocket expenses on discontinuation of statin therapy: a cohort study in Finland. J Clin Pharm Ther. 2012;37(1):58-64.
dc.source.bibliographicCitationToenders W. Patient compliance in medical practice and clinical trials. The International journal of risk & safety in medicine. 1992;3(5):338.
dc.source.bibliographicCitationZedler BK, Kakad P, Colilla S, Murrelle L, Shah NR. Does packaging with a calendar feature improve adherence to self-administered medication for long-term use? A systematic review. Clin Ther. 2011;33(1):62-73.
dc.source.bibliographicCitationZedler BK, Joyce A, Murrelle L, Kakad P, Harpe SE. A pharmacoepidemiologic analysis of the impact of calendar packaging on adherence to self-administered medications for long-term use. Clin Ther. 2011;33(5):581-97.
dc.source.bibliographicCitationMahtani KR, Heneghan CJ, Glasziou PP, Perera R. Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Syst Rev. 2011(9):Cd005025.
dc.source.bibliographicCitationBoeni F, Spinatsch E, Suter K, Hersberger KE, Arnet I. Effect of drug reminder packaging on medication adherence: a systematic review revealing research gaps. Syst Rev. 2014;3:29.
dc.source.bibliographicCitationShrank WH, Gleason PP, Canning C, Walters C, Heaton AH, Jan S, et al. Can improved prescription medication labeling influence adherence to chronic medications? An evaluation of the Target pharmacy label. J Gen Intern Med. 2009;24(5):570-8.
dc.source.bibliographicCitationGiuffrida A, Torgerson DJ. Should we pay the patient? Review of financial incentives to enhance patient compliance. Bmj. 1997;315(7110):703-7.
dc.source.bibliographicCitationVolpp KG, Loewenstein G, Troxel AB, Doshi J, Price M, Laskin M, et al. A test of financial incentives to improve warfarin adherence. BMC Health Serv Res. 2008;8:272.
dc.source.bibliographicCitationBarnett PG, Sorensen JL, Wong W, Haug NA, Hall SM. Effect of incentives for medication adherence on health care use and costs in methadone patients with HIV. Drug Alcohol Depend. 2009;100(1-2):115-21.
dc.source.bibliographicCitationJeffery RW. Financial incentives and weight control. Prev Med. 2012;55 Suppl:S61-7.
dc.source.bibliographicCitationJohn LK, Loewenstein G, Troxel AB, Norton L, Fassbender JE, Volpp KG. Financial incentives for extended weight loss: a randomized, controlled trial. J Gen Intern Med. 2011;26(6):621-6.
dc.source.bibliographicCitationLeahey TM, Subak LL, Fava J, Schembri M, Thomas G, Xu X, et al. Benefits of adding small financial incentives or optional group meetings to a web-based statewide obesity initiative. Obesity (Silver Spring). 2015;23(1):70-6.
dc.source.bibliographicCitationNaito NA, Higgins ST. Controlling health care costs in the military: the case for using financial incentives to improve beneficiary personal health indicators. Prev Med. 2012;55 Suppl:S113-5.
dc.source.bibliographicCitationHenderson C, Knapp M, Yeeles K, Bremner S, Eldridge S, David AS, et al. Cost- Effectiveness of Financial Incentives to Promote Adherence to Depot Antipsychotic Medication: Economic Evaluation of a Cluster-Randomised Controlled Trial. PLoS One. 2015;10(10):e0138816.
dc.source.bibliographicCitationDaugherty JB, Maciejewski ML, Farley JF. The impact of manufacturer coupon use in the statin market. J Manag Care Pharm. 2013;19(9):765-72.
dc.source.bibliographicCitationMatlin OS, Kymes SM, Averbukh A, Choudhry NK, Brennan TA, Bunton A, et al. Community pharmacy automatic refill program improves adherence to maintenance therapy and reduces wasted medication. Am J Manag Care. 2015;21(11):785-91.
dc.source.bibliographicCitationFrank MB, Fendrick AM, He Y, Zbrozek A, Holtz N, Leung S, et al. The effect of a large regional health plan's value-based insurance design program on statin use. Med Care. 2012;50(11):934-9.
dc.source.bibliographicCitationYu B, Zhang X, Wang G. Full coverage for hypertension drugs in rural communities in China. Am J Manag Care. 2013;19(1):e22-9.
dc.source.bibliographicCitationHansen RA, Chen SY, Gaynes BN, Maciejewski ML. Relationship of pharmaceutical promotion to antidepressant switching and adherence: a retrospective cohort study. Psychiatr Serv. 2010;61(12):1232-8.
dc.source.bibliographicCitationKing M, Bearman, P.S. Gifts and influence: Conflict of interest policies and prescribing of psychotropic medications in the United States, Social Science & Medicine . doi:101016/jsocscimed201611010. 2016.
dc.source.bibliographicCitationP. B. Filling in the Gaps: Priming and the Ethics of Pharmaceutical Advertising. . Kennedy Inst Ethics J junio de 2015;25(2):193-230.
dc.source.bibliographicCitationMintzes B LJ, Sutherland JM, Beaulieu M-D, Wilkes MS, Durrieu G, et al. . Pharmaceutical Sales Representatives and Patient Safety: A Comparative Prospective Study of Information Quality in Canada, France and the United States. . J GEN INTERN MED 1 de octubre de 2013;28(10):1368-75.
dc.source.bibliographicCitationYeh JS FJ, Avorn J, Landon J, Kesselheim AS. . Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts. . JAMA Intern Med 1 de junio de 2016;176(6):763-8.
dc.source.bibliographicCitationDemonceau J, Ruppar T, Kristanto P, Hughes DA, Fargher E, Kardas P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs. 2013;73(6):545-62.
dc.source.bibliographicCitationSapkota S, Brien JA, Greenfield JR, Aslani P. A Systematic Review of Interventions Addressing Adherence to Anti-Diabetic Medications in Patients with Type 2 Diabetes--Components of Interventions. PLoS One. 2015;10(6):e0128581.
dc.source.bibliographicCitationVera Halpern LML, David A Grimes, Laurie L Stockton, Maria F Gallo. Strategies to improve adherence and acceptability of hormonal methods of contraception. Cochrane Database of Systematic Reviews. 2013;Art. No.: CD004317. DOI: 10.1002/14651858.CD004317.pub4.(10).
dc.source.bibliographicCitationBerenson AB, Rahman M. A randomized controlled study of two educational interventions on adherence with oral contraceptives and condoms. Contraception. 2012;86(6):716-24.
dc.source.bibliographicCitationCanto De Cetina TE, Canto P, Ordonez Luna M. Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate. Contraception. 2001;63(3):143-6.
dc.source.bibliographicCitationGilliam M, Knight S, McCarthy M, Jr. Success with oral contraceptives: a pilot study. Contraception. 2004;69(5):413-8.
dc.source.bibliographicCitationKirby D RT, Thrush G, Yuen C, Sokoloff A, Potter SC. Impact of an intervention to improve contraceptive use through follow-up phone calls to female adolescent clinic patients. Perspectives on Sexual and Reproductive Health. 2010;42(4):251–7.
dc.source.bibliographicCitationKeder LM, Rulin MC, Gruss J. Compliance with depot medroxyprogesterone acetate: a randomized, controlled trial of intensive reminders. Am J Obstet Gynecol. 1998;179(3 Pt 1):583-5.
dc.source.bibliographicCitationHou MY, Hurwitz S, Kavanagh E, Fortin J, Goldberg AB. Using daily text- message reminders to improve adherence with oral contraceptives: a randomized controlled trial. Obstet Gynecol. 2010;116(3):633-40.
dc.source.bibliographicCitationCastano PM, Bynum JY, Andres R, Lara M, Westhoff C. Effect of daily text messages on oral contraceptive continuation: a randomized controlled trial. Obstet Gynecol. 2012;119(1):14-20.
dc.rights.ccAtribución-NoComercial 2.5 Colombia
dc.rights.licenciaEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc/2.5/co/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc/2.5/co/

 

Reconocimientos: